Barings Hong Kong China A vs UBS Lux Equity Fund Biotech USD

Barings Hong Kong China A vs UBS Lux Equity Fund Biotech USD

1. Barings Hong Kong China A

  • Security

    Barings Hong Kong China A USD Inc

  • Fee

    1.25%

  • ISIN

    IE0000829238

  • Holdings

    18

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 19 holdings in Barings Hong Kong China A, where the largest holding is Tencent (9.55), followed by Alibaba (8.99) and China Construction Bank (5.24). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.9) and Moderna (9.21).

All Holdings

Here we compare the holdings in Barings Hong Kong China A and UBS Lux Equity Fund Biotech USD.

Barings Hong Kong China A UBS Lux Equity Fund Biotech USD
1. Tencent
China
9.55 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Alibaba Group Holding Ltd ADR
China
8.99 %
2. Vertex Pharmaceuticals Inc
9.9 %
3. China Construction Bank Corp Class H
China
5.24 %
3. Moderna Inc
9.21 %
4. Meituan Class B
China
4.96 %
4. Alnylam Pharmaceuticals Inc
6.54 %
5. JD.com Inc
China
4.54 %
5. AbbVie Inc
USA
5.52 %
6. Xiaomi Corp Class B
China
4.3 %
6. Gilead Sciences Inc
USA
4.66 %
7. Pinduoduo Inc
China
4.17 %
7. Amgen Inc
4.32 %
8. Ping An Insurance Co
China
3.47 %
8. BioNTech SE
4.13 %
9. NetEase ADR
China
3.15 %
9. Karuna Therapeutics Inc
3.75 %
10. China Merchants Bank Class H
China
2.65 %
10. Royalty Pharma Plc
3.28 %
11. Trip.com Group Ltd
Singapore
2.21 %
-
12. Agricultural Bank of China Ltd Class H
China
2.16 %
-
13. China Pacific Insurance Co Ltd Class H
China
2.1 %
-
14. BYD Co Ltd Class H
China
2.08 %
-
15. Li Auto Inc
China
1.55 %
-
16. BeOne Medicines Ltd
China
1.44 %
-
17. PetroChina Co Ltd Class H
China
1.32 %
-
18. China Shenhua Energy Co Ltd Class H
China
1.3 %
-

The list of fund holdings was last updated on April 17, 2025.